X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Nasal Spray Shows Its Effect Against New COVID Variants

    Mid-Point Regulatory Science Strategy Study Published By EMA

    AADC Inadequacy To Be Handled By A Novel Gene Therapy

    New Drug Explored For Epilepsy Gets $3M Funding In Australia

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Faster Clinical Trial Nods Planned By The UK To Curb Issues

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    Pharma Drugs Gain From Tardigrade Proteins, Says Research

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    EMA Keeping A Close Watch On Critical Medicine Shortages

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Pathways Laid Down By The CMS For Drug Price Negotiations

    Efficacy Shown On Cystic Fibrosis Patients In 4-Year Study

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Facilities & Operation

India Keen To Establish National Database On Dosage Forms

Content Team by Content Team
9th December 2022
in Facilities & Operation, News
Chinas Institute of Materia Medica Partners With Cyclica on Innovative Drug Repurposing for COVID-19

In an effort to better inform and empower consumers, the Indian government has announced plans to create a comprehensive database on every medicinal composition supplied there.

The Ministry of Health and Family Welfare (MoHFW) of India announced plans to compile a thorough database of drug formulations produced and sold in the nation. The database will include information on a drug’s dosage form, potency, and producer, marketer, or importer.

The Indian Ministry of Health and Family Welfare (MoHFW) will form a committee to review an existing database in order to prepare the National Drugs Database. The committee will include the commissioner of the Food and Drug Control Administration (FDCA), physicians from prestigious public hospitals, researchers from the Indian Council of Medical Research, as well as several state drug controllers.

The government’s latest proposal, according to Fitch Solutions, will help address the issue of the subpar quality of drugs available on the market and ensure that medications are of established quality and safe to use.

By ensuring that all medications are of the same high standard, the Indian government’s increased efforts will also enhance the country’s pharmaceutical industry. As a result, doctors working in India who are concerned about fake and subpar drugs on the market will prescribe prescriptions with more assurance, increasing their distribution and uptake in the market, according to the report.

The quality of Indian pharmaceutical products has raised concerns on a national and international level, and companies occasionally fail to follow Good Manufacturing Practice (GMP), according to Fitch.

As a significant exporter of generic medications, India is frequently investigated by US and European drug regulators. 46 pharmaceutical companies in India had their licences revoked and received warning letters in 2021 for a variety of quality-related issues. As a result, concerns about subpar quality may be tracked back to their source with the National Drugs Database, bolstering the country’s pharmaceutical sector, the report added.

To continue to be a reputable and high-quality supplier of medicines around the world, the Indian pharmaceutical industry will need to continually invest in raising quality standards, according to Fitch. However, the research raised doubts that the database will be implemented in the near future, particularly given that it depends on all supply chain participants to function.

Implementing the platform and connecting the thousands of medication producers, their warehouses, and suppliers all throughout India will be difficult, they predicted.

Previous Post

New Decoy Medication Neutralises COVID-19 And Variations

Next Post

Market For Oligonucleotides Forecast To Hit $16.7bn By 2027

Related Posts

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Drugs Gain From Tardigrade Proteins, Says Research
Drug Development

Pharma Drugs Gain From Tardigrade Proteins, Says Research

22nd March 2023
Next Post

Market For Oligonucleotides Forecast To Hit $16.7bn By 2027

Latest News

Drug Development

Nasal Spray Shows Its Effect Against New COVID Variants

27th March 2023
FDA Approvals

Mid-Point Regulatory Science Strategy Study Published By EMA

27th March 2023
Drug Development

AADC Inadequacy To Be Handled By A Novel Gene Therapy

24th March 2023
Drug Development

New Drug Explored For Epilepsy Gets $3M Funding In Australia

23rd March 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Faster Clinical Trial Nods Planned By The UK To Curb Issues

22nd March 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In